Indian Journal of Clinical Biochemistry

, Volume 26, Issue 2, pp 146–153 | Cite as

Quantitative Assessment of Expression of Lactate Dehydrogenase and its Isoforms 3 and 4 may Serve as Useful Indicators of Progression of Gallbladder Cancer: A Pilot Study

  • Tekcham Dinesh Singh
  • Mustafa Ahmed Barbhuiya
  • Sanjeev Gupta
  • Braj Raj Shrivastav
  • Viswajit Jalaj
  • Nidisha Agarwal
  • Pramod Kumar Tiwari
Original Article

Abstract

We have studied the expression of lactate dehydrogenase and its isoforms in gall bladder cancer, cholelithiasis and chronic cholecystitis. Quantitative and qualitative assays of lactate dehydrogenase and its various isoforms were carried out in the blood sera of patients and healthy controls along with parallel estimation of various liver function test enzymes. Statistical analysis was done using the software Graph Pad Prism. Significantly high expression of lactate dehydrogenase along with alkaline phosphatase and total bilirubin (P ≤ 0.05) was observed in all the three clinical conditions as compared to controls. LDH showed an increasing trend from stage I to stage IV of GBC indicating a significant positive association with the disease progression. The levels of LDH 3 and 4 isoforms appeared significantly more elevated in GBC than cholelithiasis or chronic cholecystitis. We suggest that a careful estimation of total LDH and its isoforms 3 and 4 alone or along with alkaline phosphatase and total bilirubin during different clinical stages, like chronic cholecystitis, cholelithiasis and GBC, may prove to be a potentially useful biomarker in the prognostic management of gall bladder diseases, specifically GBC.

Keywords

Gallbladder cancer Lactate dehydrogenase Cholelithiasis Chronic cholecystitis 

References

  1. 1.
    De Stoll M. Rationis mendendi, in nosocomio practico vendobonensi, part-I lugaumi batavanum. In: Haak et. Socios. et. A et. J Honkoop. Lugduni Batavorum: Amstelaedami; 1788.Google Scholar
  2. 2.
    Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update. Histopathol. 2009. doi:10.1111/j.1365-2559.2008.03192.x.
  3. 3.
    Barbhuiya MA, Singh TD, Gupta S, Shrivastav BR, Tiwari PK. Incidence of gall bladder cancer in rural and semi urban population of north-central India. A first insight. Internet J Epidemiol. 2009;7:2–25.Google Scholar
  4. 4.
    Lazcano-Ponce E, Miquel JF, Ferrecio C, Wistuba I, Munoz N, Alonso de Ruiz P, et al. Epidemiology and molecular pathology of gall bladder cancer. CA Cancer J Clin. 2001;51:349–64.PubMedCrossRefGoogle Scholar
  5. 5.
    Holbrook JJ, Liljas A, Steindel SJ, Rossman MG. Lactate dehydrogenase. In: The enzyme Boyer PD. Vol. XI, 3rd ed. New York: Academic Press; 1975. p. 191–292.Google Scholar
  6. 6.
    Harris AL. Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38–47.PubMedCrossRefGoogle Scholar
  7. 7.
    Le A, Coopera CR, Gouwb AM, Dinavahia R, Maitra A, Deck LM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci. 2010;107:2037–42.PubMedCrossRefGoogle Scholar
  8. 8.
    Sevince E, Sari R, Fadillioglu E. The utility of lactate dehydrogenase isoenzyme pattern in the diagnostic evaluation of malignant and non-malignant ascites. J Natl Med Assoc. 2005;97:79–84.Google Scholar
  9. 9.
    Drent M, Cobben NAM, Henderson RF, Wouters EFM, Dieijen-Visser MV. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J. 1996;9:1736–42.PubMedCrossRefGoogle Scholar
  10. 10.
    Chen Y, Zhang H, Xu A, Li N, Liu J, Liu C, et al. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer. 2006;54:95–102.PubMedCrossRefGoogle Scholar
  11. 11.
    Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL. Lactate dehydrogenase 5 expression in operable colorectal cancer: Strong association with survival and activated vascular endothelial growth factor pathway-a report of the Tumour Angiogenesis Research Group. J Clin Oncol. 2006;24:4301–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Karan D, Kelly DL, Rizzino A, Lin MF, Batra SK. Expression profile of differentially regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis. 2002;23:967–76.PubMedCrossRefGoogle Scholar
  13. 13.
    Pravonen T, Liippo K, Aronen H, Kiistala U. Lactate dehydrogenase creatine kinase and their isoenzymes in pleural effusions. Clin Chem. 1991;37:1909–12.Google Scholar
  14. 14.
    Lossos IS, Intrator O, Berkman N, Breuer R. Lactate dehydrogenase isoenzyme analysis for the diagnosis of pleural effusions in hemato-oncoligical patients. Respir Med. 1999;93:338–41.PubMedCrossRefGoogle Scholar
  15. 15.
    Schneider RJ, Seibert K, Passe S, Little C, Gee T, Lee BJ, et al. Prognostic significance of serum lactate dehydrogenase in malignant lymphoma. Cancer. 1980;46:139–43.PubMedCrossRefGoogle Scholar
  16. 16.
    Castaldo G, Oriani G, Cimino L, Budillon G, Salvatore F, Sacchetti L. Serum lactate dehydrogenase isoenzymes 4/5 ratio discriminates between hepatocarcinoma and secondary liver neoplasia. Clin Chem. 1991;37:1419–23.PubMedGoogle Scholar
  17. 17.
    Bach MK, Brashler JR, Petzold EN, Sanders ME. Superoxide production by human eosinophils can be inhibited in an agonist selective manner. J Immunol Methods. 1991;142:243.PubMedCrossRefGoogle Scholar
  18. 18.
    Sharma PR, Jain S, Tiwari PK. Elevated level of serum LDH-2 & LDH-3 in sputum three positive TB patients of Sahariya tribe: a preliminary study. Clin Biochem. 2007;40:1414–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Sharma PR, Jain S, Bamezai RNK, Tiwari PK. Utility of serum LDH and its isoforms in the assessment of Mycobacterium tuberculosis induced pathology in TB patients of Sahariya tribe. Ind J Clin Biochem. 2010;25:57–63.CrossRefGoogle Scholar
  20. 20.
    King EJ, Armstrong AR. A convenient method for determining serum and bile phosphatase activity. Can Med Ass J. 1934;31:376–81.PubMedGoogle Scholar
  21. 21.
    Reitman F. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957;28:56–63.PubMedGoogle Scholar
  22. 22.
    Malloy TH, Evelyn KA. The determination of bilirubin with the photoelectric colorimeter. J Biol Chem. 1937;119:481–90.Google Scholar
  23. 23.
    Graph pad prism5. San Diego, California, USA. www.graphpad.com.
  24. 24.
    Giatromanolaki A, Sivridis E, Gatter KC, Turley H, Harris AL, Koukourakis MI. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. Gynecol Oncol. 2006;103:912–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Arseneau JC, Canellos GP, Banks PM, Berard CW, Gralnick HR, DeVita VT Jr. American Burkitt’s lymphoma: a clinicopathologic study of 30 cases: I. Clinical factors relating to prolonged survival. Am J Med. 1975;58:314–21.PubMedCrossRefGoogle Scholar
  26. 26.
    Warburg O. On the origin of cancer cells. Science. 1956;123:309–14.PubMedCrossRefGoogle Scholar
  27. 27.
    Koukourakis MI, Kontomanolis E, Giatromanolaki A, Sivridis E, Liberis V. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases. Gynecol Obstet Invest. 2008;67:162–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Zhuang L, Scolyer RA, Murali R, McCarthy SW, Zhang Xu D, Thompson JF, et al. Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Mod Pathol. 2010;23:45–53.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2011

Authors and Affiliations

  • Tekcham Dinesh Singh
    • 1
  • Mustafa Ahmed Barbhuiya
    • 1
  • Sanjeev Gupta
    • 2
  • Braj Raj Shrivastav
    • 3
    • 4
  • Viswajit Jalaj
    • 3
  • Nidisha Agarwal
    • 3
  • Pramod Kumar Tiwari
    • 1
  1. 1.Centre for Genomics, Molecular and Human Genetics, School of Studies in ZoologyJiwaji UniversityGwaliorIndia
  2. 2.Department of PathologyCancer Hospital and Research Institute (CHRI)GwaliorIndia
  3. 3.Department of Surgery Cancer Hospital and Research Institute (CHRI)GwaliorIndia
  4. 4.Department of Surgery Gajra Raja Medical College (GRMC)GwaliorIndia

Personalised recommendations